Skip to main content
MEDICALSYSTEM BIOTECHNOLOGY CO., LTD logo

MEDICALSYSTEM BIOTECHNOLOGY CO., LTD — Investor Relations & Filings

Ticker · 300439 ISIN · CNE100001Z25 LEI · 3003007XTAWFVR8ASC23 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,715 across all filing types
Latest filing 2023-12-18 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300439

About MEDICALSYSTEM BIOTECHNOLOGY CO., LTD

https://www.nbmksw.com

MedicalSystem Biotechnology Co., Ltd. specializes in the research, development, production, and distribution of in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio that includes biochemical reagents, chemiluminescence immunoassay systems, molecular diagnostic kits, and point-of-care testing (POCT) solutions. Its product line covers a wide range of clinical applications such as liver function, kidney function, blood lipids, and cardiovascular markers. MedicalSystem is recognized for its integrated business model, which combines the manufacturing of high-quality diagnostic instruments with a vast array of compatible reagents. Additionally, the company provides third-party medical laboratory services to healthcare institutions. By focusing on technological innovation and standardized production, MedicalSystem supports clinical laboratories in achieving accurate and efficient diagnostic results for improved patient care.

Recent filings

Filing Released Lang Actions
第五届董事会第二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's fifth board of directors' second meeting, including approval of a restricted stock incentive plan. It includes details about the meeting date, attendance, voting results, and related disclosures. There is no financial report or detailed financial data presented. The document is an announcement of board decisions, specifically about stock incentive plans and related governance matters. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short (1209 characters), and it is not a report or presentation but a formal meeting resolution announcement.
2023-12-18 Chinese
独立董事关于公司第五届董事会第二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of 美康生物科技股份有限公司 regarding the second meeting of the fifth board of directors. It discusses the approval and compliance of a 2023 restricted stock incentive plan, including legal and regulatory adherence, board procedures, and the granting of restricted shares. The document is a formal opinion related to board matters and governance, not a financial report, earnings release, or regulatory announcement. It does not contain financial statements or earnings data, nor is it a notice of voting results or a proxy statement. The content aligns with board/management information, specifically about board decisions and opinions on corporate governance matters related to stock incentives. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and focused on board opinions, not a full report or announcement of a report publication.
2023-12-18 Chinese
北京国枫（杭州）律师事务所关于美康生物科技股份有限公司2023年第一次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, qualifications of attendees, and voting results of the 2023 first extraordinary general meeting (临时股东大会) of Meikang Biotechnology Co., Ltd. It details the legality and validity of the meeting's process and outcomes, including election of board members and approval of various proposals. The document does not contain financial statements or financial performance data, nor is it a report of financial results. It is not a simple announcement but a legal opinion on the meeting's conduct and voting results. This type of document corresponds to a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes and related procedural confirmations of a shareholders' meeting.
2023-12-15 Chinese
关于董事会、监事会完成换届选举及聘任公司高级管理人员、证券事务代表的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement from 美康生物科技股份有限公司 regarding the completion of the board of directors and supervisory board re-election, as well as the appointment of senior management and securities affairs representatives. It includes detailed information about the composition of the new board, committees, supervisory board, and senior management, along with their qualifications and resumes. The document is not a financial report, earnings release, or regulatory filing about financial results. It is not a proxy statement or voting results announcement. The content focuses on management and board changes, which fits the category of Board/Management Information (MANG). The document length is about 9,794 characters, which is substantive and contains detailed information about management changes, not just a brief announcement or certification. Therefore, the appropriate classification is MANG with high confidence.
2023-12-15 Chinese
2023年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 first extraordinary general meeting (临时股东大会) of 美康生物科技股份有限公司. It includes information about the meeting date, attendance, voting results on various proposals including board elections, amendments to company bylaws, and stock incentive plans. The document is not a full annual or interim report, nor is it a transcript or earnings release. It is not a simple announcement of voting results but a comprehensive disclosure of the meeting's resolutions and voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6567 characters) and detailed voting data support this classification with high confidence.
2023-12-15 Chinese
独立董事关于公司第五届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 100% confidence The document is an independent opinion from the independent directors regarding the appointment of senior management at the company's fifth board meeting. It references compliance with relevant laws and regulations and confirms the legitimacy of the appointment process. There are no financial statements, earnings data, or report attachments. The content focuses on board/management changes, specifically the appointment of the general manager, deputy general managers, financial director, and board secretary. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and does not indicate it is an announcement of a report publication or a certification letter, so it is not RPA or RNS.
2023-12-15 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.